These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22245894)

  • 21. Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression.
    Huang CK; Iwagami Y; Aihara A; Chung W; de la Monte S; Thomas JM; Olsen M; Carlson R; Yu T; Dong X; Wands J
    PLoS One; 2016; 11(3):e0150336. PubMed ID: 26954680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma.
    Zhou Q; Lin J; Yan Y; Meng S; Liao H; Chen R; He G; Zhu Y; He C; Mao K; Wang J; Zhang J; Zhou Z; Xiao Z
    J Exp Clin Cancer Res; 2022 Jan; 41(1):13. PubMed ID: 34996491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
    Unitt E; Rushbrook SM; Marshall A; Davies S; Gibbs P; Morris LS; Coleman N; Alexander GJ
    Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-tumor efficacy of a hepatocellular carcinoma vaccine based on dendritic cells combined with tumor-derived autophagosomes in murine models.
    Su S; Zhou H; Xue M; Liu JY; Ding L; Cao M; Zhou ZX; Hu HM; Wang LX
    Asian Pac J Cancer Prev; 2013; 14(5):3109-16. PubMed ID: 23803088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer cell-intrinsic STING is associated with CD8 + T-cell infiltration and might serve as a potential immunotherapeutic target in hepatocellular carcinoma.
    Zhang Y; Zhai Q; Feng X; Chen D; Lu Y; Hu J; Xie H; Zhou L; Wu J; Zheng S
    Clin Transl Oncol; 2021 Jul; 23(7):1314-1324. PubMed ID: 33502741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapeutic strategies for treatment of hepatocellular carcinoma with antigen-loaded dendritic cells: in vivo study.
    El-Ashmawy NE; El-Zamarany EA; Khedr EG; El-Bahrawy HA; El-Feky OA
    Clin Exp Med; 2018 Nov; 18(4):535-546. PubMed ID: 30062618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
    Gonzalez-Carmona MA; Lukacs-Kornek V; Timmerman A; Shabani S; Kornek M; Vogt A; Yildiz Y; Sievers E; Schmidt-Wolf IG; Caselmann WH; Sauerbruch T; Schmitz V
    Hepatology; 2008 Jul; 48(1):157-68. PubMed ID: 18537185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen-loaded dendritic cells triggers a specific cytotoxic T lymphocytes immune response against hepatocellular carcinoma: in vitro study.
    El-Ashmawy NE; El-Zamarany EA; Khedr EG; El-Bahrawy HA; El-Feky OA
    Clin Transl Oncol; 2019 May; 21(5):636-645. PubMed ID: 30368725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes.
    Margalit M; Shibolet O; Klein A; Elinav E; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2005 Jun; 115(3):443-9. PubMed ID: 15688366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspartate β-hydroxylase as a target for cancer therapy.
    Kanwal M; Smahel M; Olsen M; Smahelova J; Tachezy R
    J Exp Clin Cancer Res; 2020 Aug; 39(1):163. PubMed ID: 32811566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis.
    Nagaoka K; Ogawa K; Ji C; Cao KY; Bai X; Mulla J; Cheng Z; Wands JR; Huang CK
    Dig Dis Sci; 2021 Apr; 66(4):1080-1089. PubMed ID: 32445050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspartate β-Hydroxylase Is Upregulated in Head and Neck Squamous Cell Carcinoma and Regulates Invasiveness in Cancer Cell Models.
    Mukherjee P; Zhou X; Galli S; Davidson B; Zhang L; Ahn J; Aljuhani R; Benicky J; Ailles L; Pomin VH; Olsen M; Goldman R
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic cell-based vaccine targeting aspartate-β-hydroxylas represents a promising therapeutic strategy for HCC.
    Zhou Y; Li C; Shi G; Xu X; Luo X; Zhang Y; Fu J; Chen L; Zeng A
    Immunotherapy; 2019 Nov; 11(16):1399-1407. PubMed ID: 31608722
    [No Abstract]   [Full Text] [Related]  

  • 34. Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue, and its possible role in tumor immunity.
    Wan YL; Zheng SS; Zhao ZC; Li MW; Jia CK; Zhang H
    World J Gastroenterol; 2004 Jan; 10(2):195-9. PubMed ID: 14716821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL-12 in vivo.
    Vogt A; Sievers E; Lukacs-Kornek V; Decker G; Raskopf E; Meumann N; Büning H; Sauerbruch T; Strassburg CP; Schmidt-Wolf IG; Gonzalez-Carmona MA
    Liver Int; 2014 Mar; 34(3):447-61. PubMed ID: 23998316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
    Homma S; Komita H; Sagawa Y; Ohno T; Toda G
    Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction and Characterization of Adenovirus Vectors Encoding Aspartate-
    Zhou Y; Liu F; Li C; Shi G; Xu X; Luo X; Zhang Y; Fu J; Zeng A; Chen L
    J Immunol Res; 2018; 2018():9832467. PubMed ID: 30116759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-culture of primary human tumor hepatocytes from patients with hepatocellular carcinoma with autologous peripheral blood mononuclear cells: study of their in vitro immunological interactions.
    Doumba PP; Nikolopoulou M; Gomatos IP; Konstadoulakis MM; Koskinas J
    BMC Gastroenterol; 2013 Jan; 13():17. PubMed ID: 23331458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Administration of dendritic cells in cancer nodules in hepatocellular carcinoma.
    Kumagi T; Akbar SM; Horiike N; Kurose K; Hirooka M; Hiraoka A; Hiasa Y; Michitaka K; Onji M
    Oncol Rep; 2005 Oct; 14(4):969-73. PubMed ID: 16142359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-culture of dendritic cells and cytokine-induced killer cells effectively suppresses liver cancer stem cell growth by inhibiting pathways in the immune system.
    Yang T; Zhang W; Wang L; Xiao C; Wang L; Gong Y; Huang D; Guo B; Li Q; Xiang Y; Nan Y
    BMC Cancer; 2018 Oct; 18(1):984. PubMed ID: 30326865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.